Tailored solutions for the most challenging cancer treatments, providing precise and targeted therapy delivery where conventional methods fall short.
Our innovative approach combines CathPrint's revolutionary e-Shaft technology with three patent-pending innovations for unprecedented precision in cancer treatment.
Advanced catheter design with intelligent guidance systems allows precise navigation through the most complex anatomical pathways to reach target cancer sites with unprecedented accuracy.
Revolutionary e-Shaft technology enables real-time optimal positioning and dynamic adaptation to the treatment site, ensuring maximum therapeutic efficacy while minimizing healthy tissue impact.
Precise therapy delivery using advanced electrode arrays and controlled electric field technology for highly targeted cancer treatment with minimal side effects and maximum therapeutic impact.
Our strategic partnership with CathPrint brings cutting-edge e-Shaft technology to cancer treatment, enabling unprecedented precision and control in catheter-based therapies. This revolutionary approach transforms how we deliver targeted cancer treatments.
Precise electric field generation creates controlled therapeutic zones for targeted cancer cell treatment while actively preserving surrounding healthy tissue integrity.
Ready to learn more about our innovative catheter solutions? We'd love to discuss how our technology can advance cancer treatment.
info@embio.se
We typically respond within 24 hours
Sweden
Serving healthcare providers globally
Embio Medical AB is a pioneering medical device company developing advanced catheters for cancer therapy, focusing on the most severe cancer diseases. Our innovations are supported by CathPrint's revolutionary e-Shaft technology and three patent-pending innovations.